Literature DB >> 12773010

Principles of dermatoscopy of pigmented skin lesions.

Wilhelm Stolz1, U Semmelmayer, K Johow, Walter H C Burgdorf.   

Abstract

There has been a dramatic increase in the incidence of malignant melanoma in most parts of the world. Because the tumor thickness is the most important prognostic factor for the prognosis of the malignant melanoma, the early detection of thin melanomas is essential. Dermatoscopy allows the physician to discriminate between melanocytic and nonmelanocytic lesions with high diagnostic accuracy and to detect initial malignant melanomas. We review the principles of dermatoscopy and the differential diagnosis of pigmented skin lesions. Before using the ABCD rule of dermatoscopy to classify melanocytic lesions into benign, suspicious, or malignant, the distinction between melanocytic and nonmelanocytic lesions is necessary. An essential prerequisite for the usefulness of this technique is adequate training.

Entities:  

Mesh:

Year:  2003        PMID: 12773010     DOI: 10.1053/sder.2003.50001

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  3 in total

1.  Automated detection of malignant features in confocal microscopy on superficial spreading melanoma versus nevi.

Authors:  Dan Gareau; Ricky Hennessy; Eric Wan; Giovanni Pellacani; Steven L Jacques
Journal:  J Biomed Opt       Date:  2010 Nov-Dec       Impact factor: 3.170

2.  Histopathological diagnosis of small melanocytic lesions suspicious for malignant melanoma.

Authors:  Danielle Carvalho Quintella; Gabriella Campos-do-Carmo; Leonardo Pereira Quintella; Tullia Cuzzi
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

3.  Dermoscopic features of thin melanomas: a comparative study of melanoma in situ and invasive melanomas smaller than or equal to 1mm.

Authors:  Vanessa Priscilla Martins da Silva; Juliana Kida Ikino; Mariana Mazzochi Sens; Daniel Holthausen Nunes; Gabriella Di Giunta
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.